Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01 Clinical Trial Optional)

Funder: National Institutes of Health

Due Date: November 7, 2018

Budget: $9,000,000

Opportunity: PAR-18-244

The purpose of this funding opportunity announcement (FOA) is to invite applications to stimulate innovative collaborative research in the NCATS’ Clinical and Translational Science Award (CTSA) consortium.

PAR-15-173 encourages X02 pre-applications for the CTSA Innovation Award Program. X02 applications will be evaluated by outside experts, and applicants whose X02 pre-applications are found to be meritorious and programmatically relevant will be notified of the opportunity to submit a full application in response to this U01 FOA.

Leave a Reply